UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway

Frontiers in oncology, 2019-08, Vol.9, p.754-754

2019

Volltextzugriff (PDF)

Autophagy inhibition and reactive oxygen species elimination by acetyl-CoA acetyltransferase 1 through fused in sarcoma protein to promote prostate cancer

BMC cancer, 2022-12, Vol.22 (1), p.1313-1313, Article 1313

2022

Volltextzugriff (PDF)

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.48-15, Article 48

2019

Volltextzugriff (PDF)

Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients

Oral oncology, 2018-10, Vol.85, p.8-14

2018

Volltextzugriff (PDF)

TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling

Cancer letters, 2019-06, Vol.452, p.1-13

2019

Volltextzugriff (PDF)

SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter

Cancer letters, 2018-05, Vol.422, p.56-69

2018

Volltextzugriff (PDF)

Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression

Molecular carcinogenesis, 2024-04, Vol.63 (4), p.757-771

2024

Volltextzugriff (PDF)

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

British journal of cancer, 2018-03, Vol.118 (5), p.654-661

2018

Volltextzugriff (PDF)

FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis

Experimental cell research, 2023-10, Vol.431 (1), p.113737-113737, Article 113737

2023

Volltextzugriff (PDF)

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial

JAMA oncology, 2018-11, Vol.4 (11), p.1569

2018

Volltextzugriff (PDF)

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

Cancer biology & medicine, 2018-11, Vol.15 (4), p.443-451

2018

Volltextzugriff (PDF)

Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication

Investigational new drugs, 2022-02, Vol.40 (1), p.209-214

2022

Volltextzugriff (PDF)

Circular RNA circHECTD1 prevents Diosbulbin-B-sensitivity via miR-137/PBX3 axis in gastric cancer

Cancer cell international, 2021-05, Vol.21 (1), p.264-264, Article 264

2021

Volltextzugriff (PDF)

Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG

European journal of nuclear medicine and molecular imaging, 2022-10, Vol.49 (12), p.4145-4155

2022

Volltextzugriff (PDF)

Single-cell sequencing and bulk RNA data reveal the tumor microenvironment infiltration characteristics of disulfidptosis related genes in breast cancer

Journal of cancer research and clinical oncology, 2023-10, Vol.149 (13), p.12145-12164

2023

Volltextzugriff (PDF)

Genetic Variants That Impact Alternative Polyadenylation in Cancer Represent Candidate Causal Risk Loci

Cancer research (Chicago, Ill.), 2023-11, Vol.83 (21), p.3650-3666

2023

Volltextzugriff (PDF)

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients

Scientific reports, 2023-03, Vol.13 (1), p.3553-3553, Article 3553

2023

Volltextzugriff (PDF)

Potential Therapeutic Roles of Exosomes in Multiple Myeloma: A Systematic Review

Journal of Cancer, 2019-01, Vol.10 (24), p.6154-6160

2019

Volltextzugriff (PDF)

SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis

Oncogene, 2024-09

2024

Volltextzugriff (PDF)

Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial

Clinical cancer research, 2019-12, Vol.25 (23), p.6967-6975

2019

Volltextzugriff (PDF)

The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma

International journal of oncology, 2024-02, Vol.64 (2), Article 14

2024

Volltextzugriff (PDF)

Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (11), p.2084-2096

2022

Volltextzugriff (PDF)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma

Frontiers in oncology, 2022-10, Vol.12, p.1019106-1019106

2022

Volltextzugriff (PDF)

Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies

Journal of gastrointestinal cancer, 2024-09, Vol.55 (3), p.1144-1153

2024

Volltextzugriff (PDF)

Saturated fatty acid intake, genetic risk and colorectal cancer incidence: A large‐scale prospective cohort study

International journal of cancer, 2023-08, Vol.153 (3), p.499-511

2023

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway

Autophagy inhibition and reactive oxygen species elimination by acetyl-CoA acetyltransferase 1 through fused in sarcoma protein to promote prostate cancer

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients

TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling

SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter

Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial

Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment

Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication

Circular RNA circHECTD1 prevents Diosbulbin-B-sensitivity via miR-137/PBX3 axis in gastric cancer

Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG

Single-cell sequencing and bulk RNA data reveal the tumor microenvironment infiltration characteristics of disulfidptosis related genes in breast cancer

Genetic Variants That Impact Alternative Polyadenylation in Cancer Represent Candidate Causal Risk Loci

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients

Potential Therapeutic Roles of Exosomes in Multiple Myeloma: A Systematic Review

SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis

Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial

The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma

Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma

Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies

Saturated fatty acid intake, genetic risk and colorectal cancer incidence: A large‐scale prospective cohort study

Aktive Filter

Suchergebnisse filtern